Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection.

ABSTRACT: Envelope protein-targeted vaccines for flaviviruses are limited by concerns of antibody-dependent enhancement (ADE) of infections. Nonstructural protein 1 (NS1) provides an alternative vaccine target that avoids this risk since this protein is absent from the virion. Beyond its intracellular role in virus replication, extracellular forms of NS1 function in immune modulation and are recognized by host-derived antibodies. The rational design of NS1-based vaccines requires an extensive understanding of the antigenic sites on NS1, especially those targeted by protective antibodies. Here, we isolated human monoclonal antibodies (MAbs) from individuals previously naturally infected with WNV, mapped their epitopes using structure-guided mutagenesis, and evaluated their efficacy in vivo aga

SUBMITTER: Wessel AW 

PROVIDER: S-EPMC8510529 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature